Controversies in Heart Failure |
From the Division of Cardiology, Hennepin County Medical Center, and the University of Minnesota, Minneapolis, Minn.
Correspondence to Bradley A. Bart, MD, Division of Cardiology, O5 HCMC, 701 Park Ave S, Minneapolis, MN 55415. E-mail bartx006@umn.edu
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
—Charles F. Kettering, 1876–1958
The morbidity of decompensated heart failure is due to volume overload, a consequence of increased total body sodium.1,2 Failure to adequately reduce total body sodium contributes to progressive ventricular dysfunction, worsening heart failure, and excess morbidity. Ultrafiltration is the gold standard for sodium-volume removal and is the only intervention shown to improve outcomes in a randomized controlled trial of patients hospitalized with decompensated heart failure.3 Diuretics are inherently inferior because they produce hypotonic urine4,5and undesirable hemodynamic and neurohormonal changes.6,7 Therefore, ultrafiltration is the preferred initial treatment for patients hospitalized with decompensated heart failure and sodium-volume overload.
Response by Shin and Dec on p 499
| Sodium is the Major Determinant of Extracellular Fluid Volume |
|---|
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |